WHO approves second China-developed Covid-19 vaccine, Sinovac-CoronaVac, for emergency use
KATHMANDU, JUNE 2
The government has decided to use the second lot of Vero cell donated by the Chinese government to inoculate people in 60-64 age groups throughout the country from June 8.
All eligible people will have to go to their nearest vaccination booths as determined by the District Covid-19 Vaccine Coordination and monitoring Committee either with their Citizenship, or any other government document specifying their age, or a recommendation letter provided by ward office.
The government has said it ensures that the second dose will also be administered within the stipulated time.
The Chinese government has provided Nepal with 1 million doses of Vero cell, of which 800,000 doses of the Covid-19 vaccine arrived from Beijing in a Nepal Airlines flight on Tuesday. The remaining 200,000 doses have also been received from other regions of China.
Earlier, China had donated 800,000 doses of Vero cell, the administration of which began on April 9.
Meanwhile, the World Health Organisation (WHO) has approved the Sinovac-CoronaVac Covid-19 vaccine produced by the Beijing-based pharmaceutical Company Sinovac for emergency use. This is the second Chinese vaccine to receive WHO approval after Vero Cell.
The Sinovac-CoronaVac product is an inactivated vaccine. Its easy storage requirements make it very manageable and particularly suitable for low-resource settings, according to WHO.
